Open-source AI platform GlycemicGPT released for diabetes management

GlycemicGPT, an open-source diabetes management platform powered by artificial intelligence, has been released on GitHub. The software connects to continuous glucose monitors (CGMs) and insulin pumps to provide real-time monitoring, AI-generated briefs, pattern detection, and conversational support. The project is currently in the alpha stage and is licensed under the GNU General Public License v3.0 (GPL-3.0).

The platform is designed as a supplementary tool for educational and informational purposes only, not as a replacement for professional medical care or a regulated medical device. It is not approved by the US Food and Drug Administration (FDA) or any other regulatory body for medical use. The authors and contributors explicitly state that they are not liable for any damages, injuries, or adverse health outcomes resulting from the use of the software.

GlycemicGPT can integrate with existing Nightscout instances to add AI analysis without altering the current setup. The project also includes a mobile app with a capability-based plugin architecture for community-developed device data drivers. Funding is managed through Open Collective, with full public transaction history available to contributors and users.

The software supports Tandem Mobi hardware via the same Bluetooth Low Energy (BLE) protocol as the t:slim X2, though physical hardware validation for the Mobi is not yet complete. The developers warn that protocol compatibility does not guarantee correct operation on untested devices and that use with Mobi hardware is entirely at the user's risk.

Deployment options include a laptop, a home server with Cloudflare Tunnel, or a cloud virtual private server (VPS). The project acknowledges that large language models are known to make mistakes and advises users to verify all AI-generated suggestions, such as insulin dosing or carb ratios, with healthcare providers before use.